ASX:LYC
ASX:LYCMetals and Mining

Do Lynas Rare Earths’ (ASX:LYC) Governance Moves Clarify Or Complicate Its Critical Minerals Strategy?

At its November 26, 2025 AGM, Lynas Rare Earths approved the election of Kathleen Bozanic as a director, while investors weighed operational disruption headlines and an index profile change that sharpened focus on supply chain reliability. These developments, alongside fresh scrutiny of rare earth pricing assumptions and insider share sales for tax purposes, highlight how governance, operations, and market expectations are converging to reshape views on Lynas’s role in critical mineral...
ASX:ELV
ASX:ELVMetals and Mining

Record North American Output And Brownfield Expansion Could Be A Game Changer For Elevra Lithium (ASX:ELV)

Elevra Lithium, formed from Sayona Mining’s acquisition of Piedmont Lithium, recently reported record production at its North American Lithium mine and outlined a brownfield expansion aimed at lifting output and lowering operating costs. The expiry and cessation of nearly 14,900 unexercised options subtly reshapes Elevra Lithium’s capital structure, highlighting management’s focus on operational performance over equity dilution. With those developments in mind, we’ll explore how record North...
ASX:APA
ASX:APAGas Utilities

What APA Group (ASX:APA)'s Brigalow Peaking Power Deal With CS Energy Means For Shareholders

In late November 2025, APA Group announced a special call to discuss its Joint Development Agreement with CS Energy to develop and own the proposed Brigalow Peaking Power Plant. This collaboration highlights APA Group’s push further into peaking power generation, potentially enhancing its role in supporting grid reliability alongside renewables. We’ll now explore how the Brigalow peaking power partnership with CS Energy may reshape APA Group’s existing investment narrative and risk...
ASX:RPL
ASX:RPLCapital Markets

3 Promising ASX Penny Stocks With Under A$2B Market Cap

As Australian shares prepare for a mid-week rise, the market remains attentive to interest rate decisions both locally and in the U.S., with investors weighing their options amidst economic uncertainties. In this context, penny stocks—though often seen as relics of past market trends—still capture attention for their potential to unlock growth in lesser-known corners of the market. By focusing on companies with strong financial health, investors can find opportunities that balance stability...
ASX:KSL
ASX:KSLBanks

ASX Dividend Stocks To Boost Your Portfolio

As the Australian market experiences fluctuations with sectors like real estate showing resilience and others lagging, investors are keenly observing the Reserve Bank of Australia's decisions and their impact on indices. In such a dynamic environment, dividend stocks can offer stability and income potential, making them an attractive option for those looking to bolster their portfolios amidst market uncertainties.
ASX:LTR
ASX:LTRMetals and Mining

ASX Growth Companies With High Insider Ownership In December 2025

As the Australian market navigates a period of uncertainty, with recent RBA decisions and sector fluctuations impacting investor sentiment, attention is increasingly turning towards growth companies with high insider ownership. In such an environment, stocks where insiders hold significant stakes can often signal confidence in the company's long-term prospects, making them intriguing considerations for investors seeking stability and potential growth.
ASX:LGI
ASX:LGIRenewable Energy

ASX Stocks Estimated To Be Up To 48.3% Below Intrinsic Value

In the current Australian market landscape, recent events such as the Reserve Bank of Australia's decision to hold interest rates steady have led to mixed reactions, with major indices experiencing fluctuations and sectors like real estate showing some resilience. Amidst these conditions, identifying undervalued stocks can be a strategic approach for investors seeking opportunities that may offer potential upside when market sentiments shift.
ASX:ARX
ASX:ARXBiotechs

ASX Penny Stocks Under A$900M Market Cap To Watch

The Australian market recently experienced a brief surge following the Reserve Bank of Australia's decision to hold interest rates steady, though it settled into a slightly negative territory by the day's end. In such fluctuating conditions, identifying promising investments requires a keen eye for companies with strong financial foundations. Penny stocks, although an older term, remain relevant as they often represent smaller or newer companies that can offer unique opportunities for growth...
ASX:S32
ASX:S32Metals and Mining

Reassessing South32 (ASX:S32) Valuation After Geoff Healy’s Appointment to the Board

South32 (ASX:S32) has caught fresh attention after appointing seasoned executive Geoff Healy as an independent Non Executive Director. This governance move nudges investors to revisit the miner's long term strategy and valuation. See our latest analysis for South32. The board refresh lands as the share price trades at A$3.37, with a strong 3 month share price return of 32.2 percent but a weaker 1 year total shareholder return of minus 5.6 percent, hinting at improving momentum after a tougher...
ASX:LTR
ASX:LTRMetals and Mining

Liontown Resources (ASX:LTR): Valuation Check After New Canmax Offtake Deal Expands Lithium Supply Commitments

Liontown (ASX:LTR) has grabbed attention after signing a binding offtake deal with Canmax Technologies, locking in spodumene concentrate supply for 2027 and 2028 and deepening its ties into the global battery supply chain. See our latest analysis for Liontown. The market seems to like the story, with a 45.10% 1 month share price return and a 159.65% year to date share price return contributing to a 142.62% 1 year total shareholder return. This suggests strong momentum despite a weaker 3 year...
ASX:AYA
ASX:AYAHealthcare Services

Assessing Artrya (ASX:AYA)’s Valuation After Its New Three-Year U.S. Hospital Agreement

Artrya (ASX:AYA) has secured a three year commercial agreement to deploy its Salix platform across Northeast Georgia Health System, providing at least A$300,000 in revenue with additional potential from per scan fees. See our latest analysis for Artrya. The announcement appears to have accelerated an already powerful trend, with a 7 day share price return of 25.56 percent contributing to a 533.87 percent year to date share price return and a 727.37 percent 1 year total shareholder return...